| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.8 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.8 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.009 | 0.9 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |